GlyTR Therapeutics
Irvine · Founded 2015
About GlyTR Therapeutics
GlyTR Therapeutics develops a novel immunotherapy platform technology targeting diverse cancer types, from breast cancer to leukemia. The company is based on research that has come out of UC Irvine’s Research Lab and founded by Dr. Michael Demetriou and Dr. Raymond Zhou.
Company Facts
- Founded: 2015
- Legal name: Glytr Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (May 2016)
- Website: glytrtherapeutics.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/glytr-therapeutics-8389836 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.